Home / Resources (page 29)

Resources

RESOURCES

GLP-1s and the Gut Microbiome: Emerging Insights Into Gut–Metabolic Interactions

Scientific illustration of GLP-1 receptor activity in the intestinal lining surrounded by diverse gut microbiome bacteria, highlighting gut–metabolic interactions.

The conversation around GLP-1 therapies has shifted quickly. While most clinicians focus on weight loss and glucose lowering, new data on GLP-1 microbiome effects suggest something deeper may be happening in the gut. Could these medications reshape the intestinal ecosystem in ways that support long-term metabolic health? Increasingly, researchers believe …

Read More »

GLP-1s and Pancreatic Cancer: Reassessing Long-Term Safety Signals

Physician reviewing abdominal CT scan highlighting pancreas with GLP-1 injection pen on desk during clinical consultation

Concerns about GLP-1 pancreatic cancer risk have circulated for more than a decade. When glucagon-like peptide-1 receptor agonists first entered the market, early post-marketing reports and small observational studies raised alarms about pancreatitis and possible malignancy. As a result, clinicians and patients questioned the long-term safety of agents such as …

Read More »

GLP-1s and Atrial Fibrillation: What Do the Data Suggest?

GLP-1 injection pen beside anatomical heart with ECG monitor showing atrial fibrillation waveform

The potential link between GLP-1 therapies and atrial fibrillation is drawing increasing clinical interest as cardiometabolic care continues to evolve. Patients with type 2 diabetes face a significantly higher risk of atrial fibrillation, yet GLP-1 receptor agonists are rarely discussed in rhythm management conversations. Could medications such as semaglutide (Ozempic), …

Read More »

Nutrition Equity in Diabetes: Addressing Food Insecurity Without the Paperwork

Healthcare provider discussing nutrition with a patient beside fresh produce, food assistance boxes, and a glucometer, illustrating diabetes food insecurity support in clinical care.

Diabetes management often begins with nutrition advice. However, what happens when patients cannot afford fresh produce or live miles from a grocery store? For many people living with diabetes, food insecurity is a growing yet underrecognized barrier to glycemic control. While clinicians routinely discuss carbohydrate counting and meal planning, they …

Read More »

Bringing CGM Into the Primary Care Visit: Practical Integration for Non-Specialists

Primary care physician reviewing continuous glucose monitoring data with a patient during a diabetes visit

Continuous glucose monitoring was once reserved for endocrinology clinics. Today, integrating CGM into primary care is essential as guidelines recommend earlier and broader use in both type 1 and type 2 diabetes. Yet many clinicians still feel unsure about how to interpret reports or fit CGM into a busy visit. …

Read More »

Post-Discharge Diabetes Care: Preventing Lapses in the First 30 Days

Hospital discharge checklist with glucose meter, insulin, and medications for safe diabetes transition care

Hospital discharge should mark a fresh start. However, for many patients, the period after a diabetes hospital discharge becomes a danger zone. The days following a hospital discharge for diabetes are often marked by hypoglycemia, medication confusion, and missed follow-up visits. In fact, the first 30 days often determine whether …

Read More »

Navigating Oral GLP-1s: When to Choose Pills Over Injections

Comparison of oral GLP-1 therapy tablets and injectable GLP-1 pens used for type 2 diabetes treatment

Oral GLP-1 therapy is quickly reshaping how we treat type 2 diabetes, especially for patients who hesitate at the thought of injections. For years, glucagon-like peptide-1 receptor agonists were only available as injectables such as semaglutide and dulaglutide. However, the introduction of semaglutide tablets and the development of higher-dose oral …

Read More »

GLP‑1s and Racial/Ethnic Disparities: How Response and Access May Vary

Diverse patients and clinician reviewing glucose meter and GLP-1 injection therapy in a diabetes care setting

GLP-1 receptor agonists have transformed type 2 diabetes care, improving glycemic control, supporting weight loss, and reducing cardiovascular risk. However, disparities in GLP-1 use and access are becoming harder to ignore. Why do some patients gain access quickly while others face barriers at every step? Data suggest that prescribing patterns …

Read More »

GLP-1s and Reproductive Health: What to Know About Fertility, Pregnancy, and PCOS

Female physician reviewing chart with GLP-1 injection pen in foreground and silhouette of pregnant woman, representing GLP-1 reproductive health and pregnancy considerations

GLP-1 receptor agonists are transforming diabetes and obesity care. However, as more women of reproductive age use medications like semaglutide, liraglutide, and tirzepatide, questions about how GLP-1 therapies affect fertility and pregnancy are becoming increasingly common. Can patients conceive safely while taking these agents? Do they improve ovulation in women …

Read More »

Managing GLP-1 GI Side Effects Before Stopping Therapy

Physician discussing GLP-1 GI side effects and nausea management with a patient during a diabetes consultation

GLP-1 receptor agonists have transformed type 2 diabetes care. Yet for many patients, gastrointestinal side effects from GLP-1 therapy, such as nausea, vomiting, and constipation, can threaten long-term adherence. Have you ever had a patient achieve an impressive A1C reduction but consider stopping therapy because of persistent nausea? You are …

Read More »